Correlation Between Astellas Pharma and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and Roche Holding AG, you can compare the effects of market volatilities on Astellas Pharma and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Roche Holding.

Diversification Opportunities for Astellas Pharma and Roche Holding

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Astellas and Roche is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Roche Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding AG and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding AG has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Roche Holding go up and down completely randomly.

Pair Corralation between Astellas Pharma and Roche Holding

Assuming the 90 days horizon Astellas Pharma is expected to generate 1.47 times more return on investment than Roche Holding. However, Astellas Pharma is 1.47 times more volatile than Roche Holding AG. It trades about 0.01 of its potential returns per unit of risk. Roche Holding AG is currently generating about 0.0 per unit of risk. If you would invest  1,325  in Astellas Pharma on August 27, 2024 and sell it today you would lose (357.00) from holding Astellas Pharma or give up 26.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy91.18%
ValuesDaily Returns

Astellas Pharma  vs.  Roche Holding AG

 Performance 
       Timeline  
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Roche Holding AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Astellas Pharma and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astellas Pharma and Roche Holding

The main advantage of trading using opposite Astellas Pharma and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind Astellas Pharma and Roche Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories